New Insights Into Refractory Chronic Cough and Unexplained Chronic Cough: A 6-Year Ambispective Cohort Study

被引:3
|
作者
Zhang, Mengru [1 ,2 ]
Morice, Alyn H. [2 ,4 ]
Si, Fengli [1 ]
Zhang, Li [1 ]
Chen, Qiang [1 ]
Wang, Shengyuan [1 ]
Zhu, Yiqing [1 ]
Xu, Xianghuai [1 ]
Yu, Li [1 ]
Qiu, Zhongmin [1 ,3 ]
机构
[1] Tongji Univ, Tongji Hosp, Sch Med, Dept Pulm & Crit Care Med, Shanghai, Peoples R China
[2] Univ Hull, Castle Hill Hosp, Ctr Clin Sci, Hull York Med Sch, Cottingham, East Yorks, England
[3] Tongji Univ, Tongji Hosp, Sch Med, Dept Pulm & Crit Care Med, 389 Xincun Rd, Shanghai 200065, Peoples R China
[4] Univ Hull, Castle Hill Hosp, Hull York Med Sch, Ctr Clin Sci Resp Med, Castle Rd, Cottingham HU165JQ, E Yorks, England
关键词
Cough; cough hypersensitivity syndrome; population characteristics; treatment outcome; HYPERSENSITIVITY SYNDROME; SENSITIVITY;
D O I
10.4168/aair.2023.15.6.795
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose: Only limited studies have depicted the unique features and management of refractory chronic cough (RCC) and unexplained chronic cough (UCC). These led to the initiation of this study, which reported the demographic characteristics, manifestations, and long-term outcomes on a large series of consecutive RCC/UCC patients, providing a guideline-led real-world clinical experience.Methods: Retrospective baseline information was obtained from Clinical Research Database (January 2016 to May 2021). At least 6 months after the last clinic visit, included subjects were prospectively followed up.Results: Three hundred and sixty-nine RCC and UCC patients (199 females, 53.9%) were analyzed. The median cough duration was 24.0 (12.0-72.0) months. Laryngeal symptoms were reported in 95.9% of the patients. The common triggers for coughing were talking (74.9%), pungent odors (47.3%), eating (45.5%), and cold air (42.8%). RCC was considered in 38.2%, and the remainder of 228 patients had UCC, with an equal sex distribution (P = 0.66). Among the 141 RCCs, 90.8% (128) had refractory reflux cough, which was more responsive to current treatments (P < 0.01). Although most features and test results between RCC and UCC were similar, UCC was more commonly inappropriately treated (P < 0.01). Nineteen (7.7-41.1) months after the final clinic visit, 31.2% still coughed persistently, while 68.8% reported cough improvement or remission. RCC reported more favorable treatment outcomes (including cough improvement, control, and spontaneous remission) than UCC (P < 0.01). Coughs with long duration before the initial cough clinic visit (P < 0.01), frequent urinary incontinence (P < 0.01), and being sensitive to "talking" (P < 0.01) or "cold air" (P < 0.01) were less likely to be solved.Conclusions: The current treatments only improve cough symptoms in two-thirds of patients. Clinical indicators for treatment failure were those coughing for long duration and being sensitive to "talking" or "cold air."
引用
收藏
页码:795 / 811
页数:17
相关论文
共 50 条
  • [21] Plasma and bronchoalveolar lavage ATP in refractory/unexplained chronic cough
    Digby, James Wingfield
    Wortley, Michael
    Bonvini, Sara
    Dockry, Rachel
    Issop, Sabina
    King, Jenny
    Massey, Bethany
    Stephan, Simon
    Dubois, Eric
    Galgani, Shannon
    Holt, Kimberley
    Sen, Shilpi
    Mitchell, Joanne
    Al-Sheklly, Bashar
    Belvisi, Maria
    Smith, Jacky
    Marsden, Paul
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [22] Predictors of treatment response to pregabalin in unexplained or refractory chronic cough
    St-Pierre, Mathieu D.
    RESPIRATORY MEDICINE, 2023, 218
  • [23] Mechanisms and Rationale for Targeted Therapies in Refractory and Unexplained Chronic Cough
    Mazzone, Stuart B.
    McGarvey, Lorcan
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (03) : 619 - 636
  • [24] Cough severity, physical impact, and impact on everyday life. A study on patients with refractory or unexplained chronic cough
    Davila, I.
    Puente-Maestu, L.
    Domingo, C.
    Diaz-Palacios, M.
    Sola Martinez, J.
    Cea-Calvo, L.
    Julia De Paramo, B.
    Sanchez-Jareno, M.
    Quirce, S.
    ALLERGY, 2023, 78
  • [25] Comparison of differences in refractory and unexplained chronic cough patients in Germany: VICHAS study
    Jannowitz, Christina
    Kardos, Peter
    Worth, Heinrich
    Horack, Martin
    Kohler, Ulrich
    Karmann, Barbara
    Gillissen, Adrian
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [26] Leicester Cough Questionnaire validation and clinically important thresholds for change in refractory or unexplained chronic cough
    Nguyen, Allison Martin
    Schelfhout, Jonathan
    Muccino, David
    Bacci, Elizabeth D.
    La Rosa, Carmen
    Vernon, Margaret
    Birring, Surinder S.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [27] Leicester Cough Questionnaire validation and clinically important thresholds for change in refractory or unexplained chronic cough
    Nguyen, Allison Martin
    Schelfhout, Jonathan
    Muccino, David
    Bacci, Elizabeth D.
    La Rosa, Carmen
    Vernon, Margaret
    Birring, Surinder S.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [28] Cough symptom severity in patients with refractory or unexplained chronic cough: a systematic survey and conceptual framework
    Kum, Elena
    Guyatt, Gordon H.
    Devji, Tahira
    Wang, Yuting
    Bakaa, Layla
    Lan, Lucy
    Liu, Eva
    Mastrolonardo, Alexander
    Couban, Rachel
    O'Byrne, Paul M.
    Satia, Imran
    EUROPEAN RESPIRATORY REVIEW, 2021, 30 (161):
  • [29] Correlation of visual analogue scale with Leicester Cough questionnaire in patients with refractory/unexplained chronic cough
    Domingo-Ribas, Christian
    Davila, Ignacio
    Quirce, Santiago
    Crespo-Lessmann, Astrid
    Diaz-Palacios, Miguel
    Pereira-Vega, Antonio
    Luisa Nieto, Maria
    Luis Rodriguez-Hermosa, Juan
    Cea-Calvo, Luis
    Lopez-Cotarelo, Pilar
    Sanchez Jareno, Marta
    Puente-Maestu, Luis
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [30] Impaired cough suppression in chronic refractory cough
    Cho, Peter S. P.
    Fletcher, Hannah, V
    Turner, Richard D.
    Jolley, Caroline J.
    Birring, Surinder S.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (05)